Cargando…

Predictive approaches to heterogeneous treatment effects: a scoping review

BACKGROUND: Recent evidence suggests that there is often substantial variation in the benefits and harms across a trial population. We aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial. METHODS: We performed a literature...

Descripción completa

Detalles Bibliográficos
Autores principales: Rekkas, Alexandros, Paulus, Jessica K., Raman, Gowri, Wong, John B., Steyerberg, Ewout W., Rijnbeek, Peter R., Kent, David M., van Klaveren, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585220/
https://www.ncbi.nlm.nih.gov/pubmed/33096986
http://dx.doi.org/10.1186/s12874-020-01145-1
_version_ 1783599742226268160
author Rekkas, Alexandros
Paulus, Jessica K.
Raman, Gowri
Wong, John B.
Steyerberg, Ewout W.
Rijnbeek, Peter R.
Kent, David M.
van Klaveren, David
author_facet Rekkas, Alexandros
Paulus, Jessica K.
Raman, Gowri
Wong, John B.
Steyerberg, Ewout W.
Rijnbeek, Peter R.
Kent, David M.
van Klaveren, David
author_sort Rekkas, Alexandros
collection PubMed
description BACKGROUND: Recent evidence suggests that there is often substantial variation in the benefits and harms across a trial population. We aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial. METHODS: We performed a literature review using a broad search strategy, complemented by suggestions of a technical expert panel. RESULTS: The approaches are classified into 3 categories: 1) Risk-based methods (11 papers) use only prognostic factors to define patient subgroups, relying on the mathematical dependency of the absolute risk difference on baseline risk; 2) Treatment effect modeling methods (9 papers) use both prognostic factors and treatment effect modifiers to explore characteristics that interact with the effects of therapy on a relative scale. These methods couple data-driven subgroup identification with approaches to prevent overfitting, such as penalization or use of separate data sets for subgroup identification and effect estimation. 3) Optimal treatment regime methods (12 papers) focus primarily on treatment effect modifiers to classify the trial population into those who benefit from treatment and those who do not. Finally, we also identified papers which describe model evaluation methods (4 papers). CONCLUSIONS: Three classes of approaches were identified to assess heterogeneity of treatment effect. Methodological research, including both simulations and empirical evaluations, is required to compare the available methods in different settings and to derive well-informed guidance for their application in RCT analysis.
format Online
Article
Text
id pubmed-7585220
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75852202020-10-26 Predictive approaches to heterogeneous treatment effects: a scoping review Rekkas, Alexandros Paulus, Jessica K. Raman, Gowri Wong, John B. Steyerberg, Ewout W. Rijnbeek, Peter R. Kent, David M. van Klaveren, David BMC Med Res Methodol Research Article BACKGROUND: Recent evidence suggests that there is often substantial variation in the benefits and harms across a trial population. We aimed to identify regression modeling approaches that assess heterogeneity of treatment effect within a randomized clinical trial. METHODS: We performed a literature review using a broad search strategy, complemented by suggestions of a technical expert panel. RESULTS: The approaches are classified into 3 categories: 1) Risk-based methods (11 papers) use only prognostic factors to define patient subgroups, relying on the mathematical dependency of the absolute risk difference on baseline risk; 2) Treatment effect modeling methods (9 papers) use both prognostic factors and treatment effect modifiers to explore characteristics that interact with the effects of therapy on a relative scale. These methods couple data-driven subgroup identification with approaches to prevent overfitting, such as penalization or use of separate data sets for subgroup identification and effect estimation. 3) Optimal treatment regime methods (12 papers) focus primarily on treatment effect modifiers to classify the trial population into those who benefit from treatment and those who do not. Finally, we also identified papers which describe model evaluation methods (4 papers). CONCLUSIONS: Three classes of approaches were identified to assess heterogeneity of treatment effect. Methodological research, including both simulations and empirical evaluations, is required to compare the available methods in different settings and to derive well-informed guidance for their application in RCT analysis. BioMed Central 2020-10-23 /pmc/articles/PMC7585220/ /pubmed/33096986 http://dx.doi.org/10.1186/s12874-020-01145-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Rekkas, Alexandros
Paulus, Jessica K.
Raman, Gowri
Wong, John B.
Steyerberg, Ewout W.
Rijnbeek, Peter R.
Kent, David M.
van Klaveren, David
Predictive approaches to heterogeneous treatment effects: a scoping review
title Predictive approaches to heterogeneous treatment effects: a scoping review
title_full Predictive approaches to heterogeneous treatment effects: a scoping review
title_fullStr Predictive approaches to heterogeneous treatment effects: a scoping review
title_full_unstemmed Predictive approaches to heterogeneous treatment effects: a scoping review
title_short Predictive approaches to heterogeneous treatment effects: a scoping review
title_sort predictive approaches to heterogeneous treatment effects: a scoping review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585220/
https://www.ncbi.nlm.nih.gov/pubmed/33096986
http://dx.doi.org/10.1186/s12874-020-01145-1
work_keys_str_mv AT rekkasalexandros predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT paulusjessicak predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT ramangowri predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT wongjohnb predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT steyerbergewoutw predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT rijnbeekpeterr predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT kentdavidm predictiveapproachestoheterogeneoustreatmenteffectsascopingreview
AT vanklaverendavid predictiveapproachestoheterogeneoustreatmenteffectsascopingreview